Metagenomi Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:MGX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -26.28 M-22.84 M-21.25 M-21.25 M-23.55 M -88.89 M Cash from investing activities 28.55 M24.73 M19.07 M27.36 M32.37 M 103.53 M Cash from financing activities 0-77 K-166 K-187 K74 K -356 K Free cash flow -26.61 M-23.13 M-21.38 M-21.33 M-23.63 M -89.47 M

뉴스

Buy These 3 Best Stocks Now, According to Top Wall Street Analysts, 3/6/2026 - TipRanks.com

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

What you should know about the owners of US TikTok

Oracle says data center outage causing issues faced by US TikTok users

MGX Resources, 다각화 집중: 2026년 2분기 실적 발표

Earnings call transcript: MGX Resources Q2 2026 focuses on diversification

TikTok reaches deal for new US joint venture to avoid American ban

틱톡 미국 사업부, 이번 주 내 매각 완료 전망

메타제노미, 사명 변경 및 혈우병 A형 유전자 치료 프로그램 진전

Metagenomi changes name, advances hemophilia A gene therapy program